Australia, Nov. 20 -- Soleno Therapeutics Inc., owns the trademark (2583677) for 'SOLENO ONE' till April 25, 2035.
Status: protected:
Registered/protected
Classes: 35 [Administration of patient pharmaceutical reimbursement programs; administering a patient support and assistance program for obtaining reimbursement for prescription medicines.], 38 [Communication services, namely, transmission of information relating to pharmaceuticals, medicine, and medical conditions and diseases via all means of telecommunication including the Internet.], 42 [Providing online non-downloadable software that enables users to access educational and informational materials about medical conditions and diseases, pharmaceutical product and use information, resources for patient support and advocacy programs and treatment affordability programs, and accessing pharmaceuticals via a website; providing online non-downloadable software that enables users to access educational and informational materials about medical conditions and diseases, pharmaceutical product and use information, resources for patient support and advocacy programs and treatment affordability programs, and accessing pharmaceuticals via an interactive website; providing online non-downloadable software for users to access educational and informational materials about medical conditions and diseases, pharmaceutical product and use information, resources for patient support and advocacy programs and treatment affordability programs, and accessing pharmaceuticals.] and 44 [Providing information in the field of rare diseases and treatment thereof; providing information in the fields of Prader-Willi syndrome, neurobehavioral diseases, metabolic diseases, endocrine diseases, and diseases characterized by hyperphagia, and the treatment thereof; providing medical information relating to disease awareness and disease management to improve understanding by patients and caregivers about pharmaceuticals, and providing medical information in the fields of medical products, access to medications and complying with instructions and directions for using medications and medical therapies, all the aforesaid provided through a pharmaceutical patient support program via a website.]
Type of Mark: Word
Date of Acceptance: Sept. 12
Registration Advertised: Nov. 19
For further details contact John Paul Oleksiuk Cooley LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2583677.
Disclaimer: Curated by HT Syndication.
